ProCE Banner Activity

CME

Focus on Advanced NSCLC: Expert Insights and Strategies for Refining Patient Care

Multimedia
Using interactive case scenarios, Leora Horn, MD, MSc, FRCPC, provides expert insights and practical recommendations on the management of patients with advanced NSCLC using currently available therapeutic options.

Physicians : maximum of 1.50 AMA PRA Category 1 {Credits}

Released: August 04, 2017

Expiration: August 03, 2018

No longer available for credit.

Share

Faculty

Leora Horn

Leora Horn, MD, MSc

Assistant Professor, Hematology Oncology/Medicine
Vanderbilt Ingram Cancer Center
Vanderbilt University
Nashville, Tennessee

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

Celgene

Genentech Roche Virology

Lilly

Merck Oncology

Novartis Pharmaceuticals Corporation

Target Audience

This program is intended for academic and community-based medical oncologists, pulmonologists, pathologists, and oncology nurses, as well as other healthcare professionals who treat patients with lung cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Incorporate current biomarker testing recommendations into the management of newly diagnosed patients with advanced NSCLC
  • Integrate available clinical data into the management of newly diagnosed patients with advanced NSCLC and actionable mutations
  • Apply current guideline recommendations and available clinical data to individualize the care of newly diagnosed patients with advanced-stage squamous NSCLC
  • Plan treatment strategies for patients with NSCLC and disease progression on or after platinum-containing chemotherapy based on available data, treatment guidelines, and expert recommendations
  • Manage immune-related adverse events in patients with advanced NSCLC on checkpoint inhibitor therapy

Faculty Disclosure

Primary Author

Leora Horn, MD, MSc

Assistant Professor, Hematology Oncology/Medicine
Vanderbilt Ingram Cancer Center
Vanderbilt University
Nashville, Tennessee

Leora Horn, MD,MSc, FRCPC, has disclosed that she has received consulting fees from AbbVie, Bayer, Bristol-Myers Squibb, Genentech, Lilly, Merck, and Xcovery.

Staff Disclosure

Staff

Kristen Rosenthal, PhD

Clinical Editor

Kristen Rosenthal, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 04, 2017, through August 03, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to provide educational activities and resources that will improve the competence and performance of healthcare providers to positively affect the health of patients with non-small-cell lung cancer.